Lifemd Inc (LFMD)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt LFMD? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Lifemd Inc Stock (LFMD) Company Profile

Healthcare (1200)

(866) 351-5907

236 FIFTH AVENUE, NEW YORK

Nächster Verdiensttermin

Neueste SEC-Einreichungen

LFMD's Discussions on Twitter

Vergleichen Sie LFMD mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
LFMD Lifemd Inc	6.36	283.26M	193.06M	-22.51M	10.63M	-1.04
VEEV Veeva Systems Inc	226.76	36.93B	2.57B	615.26M	996.76M	3.32
SOLV Solventum Corp	72.48	12.43B	8.26B	66.00M	1.17B	0.00
TEM Tempus Ai Inc	62.98	10.01B	640.44M	-743.28M	-206.93M	0.00
DOCS Doximity Inc	53.39	9.94B	493.63M	160.55M	162.20M	0.55
HQY Healthequity Inc	102.47	8.91B	1.10B	105.67M	-197.98M	0.1475

Lifemd Inc Stock (LFMD) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-08-23	Fortgesetzt	B. Riley Securities	Buy
2024-06-05	Eingeleitet	KeyBanc Capital Markets	Overweight
2023-11-30	Eingeleitet	Craig Hallum	Buy
2023-07-21	Eingeleitet	Cantor Fitzgerald	Overweight
2023-07-03	Eingeleitet	H.C. Wainwright	Buy
2022-03-10	Eingeleitet	Colliers Securities	Buy
2021-10-04	Fortgesetzt	B. Riley Securities	Buy

Alle ansehen

Lifemd Inc Aktie (LFMD) Neueste Nachrichten

Finanzdaten der Lifemd Inc-Aktie (LFMD)

Lifemd Inc (LFMD)

Lifemd Inc Stock (LFMD) Company Profile

Vergleichen Sie LFMD mit anderen Aktien

Lifemd Inc Stock (LFMD) Upgrades & Downgrades

Lifemd Inc Aktie (LFMD) Neueste Nachrichten

LifeMD, Inc. (NASDAQ:LFMD) Given Consensus Rating of "Buy" by Analysts - MarketBeat

(LFMD) Technical Data - Stock Traders Daily

Royce & Associates LP Boosts Stock Holdings in LifeMD, Inc. (NASDAQ:LFMD) - MarketBeat

LifeMD (NASDAQ:LFMDP) Stock Price Down 1.1% – Should You Sell? - Defense World

LifeMD, Inc. (NASDAQ:LFMD) Shares Bought by Los Angeles Capital Management LLC - MarketBeat

LifeMD (LFMD) to Present at Three Major Healthcare Investor Conferences in November | LFMDP Stock News - StockTitan

LifeMD to Participate in Three Investor Conferences During November - The Manila Times

LifeMD (LFMD) to Present at Three Major Healthcare Investor Conferences in November | LFMD Stock News - StockTitan

LifeMD Inc (NASDAQ: LFMD) Could Pass $12 In One Year Stock Forecast - Stocks Register

HC Wainwright Reiterates Buy Rating for LifeMD (NASDAQ:LFMD) - MarketBeat

LifeMD, Inc. (NASDAQ:LFMD) Q3 2024 Earnings Call Transcript - Insider Monkey

LifeMD, Inc.'s (NASDAQ:LFMD) Shares Leap 31% Yet They're Still Not Telling The Full Story - Simply Wall St

LifeMD Third Quarter 2024 Earnings: EPS Misses Expectations - Yahoo Finance

(LFMD) Technical Pivots with Risk Controls - Stock Traders Daily

LifeMD Inc (LFMD) Q3 2024 Earnings Call Highlights: Strong Teleh - GuruFocus.com

LifeMD Inc (LFMD) Q3 2024 Earnings Call Highlights: Strong Telehealth Growth and Strategic ... - Yahoo Finance

LifeMD, Inc. (LFMD) Reports Q3 Loss, Lags Revenue Estimates - MSN

LifeMD, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

LifeMD Reports Third Quarter 2024 Results - The Manila Times

LifeMD earnings beat by $0.21, revenue fell short of estimates - Investing.com UK

Institutions profited after LifeMD, Inc.'s (NASDAQ:LFMD) market cap rose US$39m last week but individual investors profited the most - Simply Wall St

Earnings to Watch: LifeMD Inc (LFMD) Reports Q3 2024 Result - GuruFocus.com

LifeMD® Launches Affiliated Pharmacy to Drive End-to-End Patient Care and Operational Efficiency - The Manila Times

Brokerages Set LifeMD, Inc. (NASDAQ:LFMD) Target Price at $12.00 - Defense World

Medifast Announces Third Quarter 2024 Financial Results - StockTitan

LifeMD, Inc. (NASDAQ:LFMD) Given Average Rating of "Buy" by Brokerages - MarketBeat

LifeMD announces board member resignation By Investing.com - Investing.com Australia

LifeMD announces board member resignation - Investing.com India

LifeMD stock touches 52-week low at $4.03 amid market challenges - Investing.com Canada

LifeMD (LFMD) Set to Announce Earnings on Thursday - MarketBeat

LifeMD Shares Decline Even After the Launch of Testosterone Therapy - MSN

LifeMD® To Report Third Quarter 2024 Financial Results On November 7 - Barchart

LifeMD launches TestoRx, direct to consumer testosterone replacement therapy - Yahoo Finance

LifeMD® to Report Third Quarter 2024 Financial Results on November 7 - GlobeNewswire

LifeMD® Launches TestoRx, a New Rex MD® Direct-to-Consumer - GlobeNewswire

LifeMD® Launches TestoRx, a New Rex MD® Direct-to-Consumer Testosterone Replacement Therapy Telehealth Offering - Yahoo Finance

The Manufacturers Life Insurance Company Purchases Shares of 13,551 LifeMD, Inc. (NASDAQ:LFMD) - Defense World

Trading Day Review: LifeMD Inc (LFMD) Gains Momentum, Closing at 4.64 - The Dwinnex

LifeMD shares hold as BTIG maintains $12 target By Investing.com - Investing.com Australia

LifeMD shares hold as BTIG maintains $12 target - Investing.com

Is it possible to buy LifeMD Inc(LFMD) shares at a good price now? - US Post News

LifeMD, Inc.'s (NASDAQ:LFMD) top owners are retail investors with 45% stake, while 38% is held by institutions - Yahoo Finance

LifeMD Inc [LFMD] stock for 14,790 USD was bought by Galluppi Stefan - Knox Daily

LifeMD Inc (LFMD) Stock: A Year of Declines and Increases - The InvestChronicle

Financial Health Check: Examining LifeMD Inc (LFMD)’s Key Ratios - The Dwinnex

LifeMD shares maintain Buy rating from B.Riley amid market demand By Investing.com - Investing.com South Africa

Finanzdaten der Lifemd Inc-Aktie (LFMD)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie LFMD